Skip to main content

Table 2 Comparison of health-related quality of life (utility) between vignettes of 2 week, 4 week and 3 month treatment regimens

From: Health-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off study

Vignette

Mean

Median

SD

Min

Max

ANOVA

Friedman Test

Vignette 2 (2 weeks)

0.61

0.65

0.25

0.00

1.00

p<0.001

p<0.001

Vignette 3 (4 weeks)

0.65

0.70

0.24

0.00

1.00

  

Vignette 4 (3 monthly)

0.70

0.75

0.23

0.05

1.00

  
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us